image description

Tag: lupus research alliance

Walk to Make a Difference for People with Lupus

July 25, 2022 During a time when health and wellness are top of mind, many are looking for creative ways to boost their own well-being — and at the same time seeking opportunities to do something truly meaningful for others. Whether you or someone you care about is living with lupus or not, you can […] Read More

Learning About Lupus COVID Precautions for World Health Day

April 6, 2022 The World Health Organization (WHO) designated today as World Health Day to focus global attention on threats to everyone’s health.  The COVID-19 pandemic has been such a threat and continues to endanger the health of those who are immunocompromised from disease or medical treatments such as people with lupus. To observe the […] Read More

Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research

NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving  representation of minorities in clinical trials and  the scientific research profession: Project CHANGE by LT and the Diversity in Lupus Research Program. The LRA has been addressing these disparities for many years and now proudly launches this […] Read More

Lupus Research Alliance Grants $6 Million in First Global Team Science Awards

This Largest-Ever Grant Will Fund Two Projects Examining Why Lupus Differs for Each Person NEW YORK, NY. Sept. 21, 2021. Today, the Lupus Research Alliance is pleased to announce the inaugural recipients of its largest grant to date, the Global Team Science Award, which will fund international, multidisciplinary research teams to unravel lupus heterogeneity with […] Read More

Important Message from CEO Kenneth Farber: U.S. FDA Approves New Lupus Treatment

August 2, 2021 Dear Friend of the Lupus Research Alliance, As we reported this morning, the lupus community has much to celebrate with the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (brand name, Saphnelo™). As a first-in-class and only new treatment for systemic lupus erythematosus in a decade, this approval marks a major […] Read More

LRA is Unraveling Lupus Heterogeneity to Turn Complexity to Cure

July 22, 2021 Why is lupus so tough to treat? Why is it so difficult to test possible new treatments in a clinical trial? Why are so many people needed for a clinical trial to prove effectiveness? And how does LRA intend to Turn Lupus Complexity to Cure? The answers lie at the core of […] Read More

LRA Writes President Supporting Dr. Janet Woodcock for FDA Commissioner

March 31, 2021 As part of the LRA’s mission to accelerate development and availability of much-needed new diagnostics and treatments for lupus, the organization’s President and CEO, Mr. Kenneth M. Farber, submitted a letter to President Joseph Biden to express LRA’s strong support for Dr. Janet Woodcock to be nominated for Commissioner of the U.S. […] Read More

New COVID-19 Vaccine Clinical Guidance and Planned Research

Important news for people with lupus as COVID-19 vaccines are on everyone’s minds.  The foremost authority in rheumatologic diseases, the American College of Rheumatology (ACR) recently issued the COVID-19 Vaccine Clinical Guidance. Developed by a panel of rheumatologists, specialists in infectious disease and public health experts, the Guidance aims to help healthcare providers make decisions with their […] Read More

Promising New Lupus Treatments Highlighted ACR Annual Meeting

Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2020. These studies include phase I trials, which test for side effects and a safe dosage; larger phase II trials, which test for effectiveness and further gauge safety; and large phase III trials, which confirm […] Read More

Lupus Research Alliance Announces Seven Recipients of the 2020 Lupus Innovation Award

NEW YORK, NY, November 9, 2020. The Lupus Research Alliance proudly announced today the 2020 Lupus Innovation Award recipients. These seven projects represent a wide breadth of scientific exploration in lupus, probing the development and progression of lupus while pointing to potential treatment approaches. The Lupus Innovation Award offers up to $150,000/year total costs for […] Read More